Hexarelin is a more potent growth hormone secretagogue with additional cardiovascular benefits but stronger side effects and a tendency toward desensitization with prolonged use
Because of this and also due to their usefulness for weight loss, compounding pharmacies have stepped in to help with supply and cost issues
notably, the FDA has approved a clinical proofofconcept study of the NR3C1 inhibitor relacorilant plus nabpaclitaxel in cancer
A peer-reviewed analysis in AIDS demonstrating that reduction in visceral adiposity is associated with an improved metabolic profile in patients receiving Tesamorelin, with patients who lost visceral fat showing improved lipids and stable glucose homeostasis documents the downstream cardiometabolic effects beyond just fat measurement
They also boost insulin production, slow digestion and make people feel full longer, helping them slim down in record time
Talaei A, Siavash M, Majidi H, et al